ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs MXN
16.6228
0.01%
Brent Oil
82.125
-0.39%
Bitcoin
70,105.80
-0.04%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Codiak BioSciences Inc (CDAK)

  7. Codiak BioSciences Inc (CDAK) Noticias

CDAK

Codiak BioSciences (CDAK)

Codiak BioSciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CDAK
FechaHoraFuenteTítuloSímboloCompañía
30/03/202317:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDAKCodiak BioSciences Inc
29/03/202305:05Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:CDAKCodiak BioSciences Inc
29/03/202305:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CDAKCodiak BioSciences Inc
27/03/202306:00GlobeNewswire Inc.Codiak BioSciences to Pursue Asset Sale through Voluntary Chapter 11 ProcessNASDAQ:CDAKCodiak BioSciences Inc
03/03/202315:03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CDAKCodiak BioSciences Inc
14/02/202311:19Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CDAKCodiak BioSciences Inc
28/11/202212:00GlobeNewswire Inc.Codiak BioSciences to Participate 5th Annual Evercore ISI HealthCONx ConferenceNASDAQ:CDAKCodiak BioSciences Inc
10/11/202208:00GlobeNewswire Inc.Codiak Presents Preclinical Data on exoASO™-STAT6 and exoASO™-C/EBPβ Programs at the Society for Immunotherapy of Cancer (SITC) 2022 Annual MeetingNASDAQ:CDAKCodiak BioSciences Inc
03/11/202215:01GlobeNewswire Inc.Codiak BioSciences Reports Third Quarter 2022 Financial Results and Operational ProgressNASDAQ:CDAKCodiak BioSciences Inc
12/10/202207:00GlobeNewswire Inc.Codiak Presents Preclinical Data Demonstrating its Pan Beta-Coronavirus Vaccine Elicits Broad Protective Immunity Against Known Variants of SARS-CoV-2 and Related SarbecovirusesNASDAQ:CDAKCodiak BioSciences Inc
05/10/202207:00GlobeNewswire Inc.Codiak to Present New Preclinical Data Demonstrating Potent Monotherapy Activity of Two Engineered Exosome Intravenous Candidates Targeting MacrophagesNASDAQ:CDAKCodiak BioSciences Inc
20/09/202215:58Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CDAKCodiak BioSciences Inc
14/09/202205:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CDAKCodiak BioSciences Inc
13/09/202204:34TipRanksCodiak BioSciences (NASDAQ: CDAK) Drops Following Planned Public OfferingNASDAQ:CDAKCodiak BioSciences Inc
12/09/202220:05GlobeNewswire Inc.Codiak Announces Pricing of $20 Million Public Offering of Common Stock and WarrantsNASDAQ:CDAKCodiak BioSciences Inc
12/09/202215:01GlobeNewswire Inc.Codiak Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:CDAKCodiak BioSciences Inc
30/08/202208:10GlobeNewswire Inc.Codiak BioSciences Announces Program Reprioritization and Corporate RestructuringNASDAQ:CDAKCodiak BioSciences Inc
04/08/202215:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CDAKCodiak BioSciences Inc
04/08/202215:01GlobeNewswire Inc.Codiak BioSciences Reports Second Quarter 2022 Financial Results and Operational ProgressNASDAQ:CDAKCodiak BioSciences Inc
03/08/202215:15GlobeNewswire Inc.Codiak BioSciences to Participate in Upcoming BTIG and Wedbush PacGrow Investor ConferencesNASDAQ:CDAKCodiak BioSciences Inc
11/07/202208:44GlobeNewswire Inc.Codiak BioSciences to Participate at William Blair Biotech Focus Conference 2022NASDAQ:CDAKCodiak BioSciences Inc
05/07/202207:33TipRanksGoldman Sachs Thinks Codiak BioSciences’ Stock is Going to RecoverNASDAQ:CDAKCodiak BioSciences Inc
05/07/202205:30GlobeNewswire Inc.CEPI and Codiak BioSciences partner to develop broadly protective Betacoronavirus vaccineNASDAQ:CDAKCodiak BioSciences Inc
02/07/202208:15TipRanksCodiak BioSciences (CDAK) Gets a Buy Rating from William BlairNASDAQ:CDAKCodiak BioSciences Inc
30/06/202205:30GlobeNewswire Inc.Codiak Provides Platform-Validating Clinical Update and Data from Phase 1 Trials of exoSTING™ and exoIL-12™NASDAQ:CDAKCodiak BioSciences Inc
29/06/202207:00GlobeNewswire Inc.Codiak Initiates Patient Dosing in Phase 1 Clinical Trial of exoASO™-STAT6 in Patients with Advanced Hepatocellular Carcinoma, Liver Metastases from Primary Gastric Cancer and Colorectal CancerNASDAQ:CDAKCodiak BioSciences Inc
17/05/202206:00GlobeNewswire Inc.Codiak Presents New Preclinical Data at ASGCT 2022 on Exosome-Based Strategy to Enhance AAV Gene TherapyNASDAQ:CDAKCodiak BioSciences Inc
05/05/202215:01GlobeNewswire Inc.Codiak BioSciences Reports First Quarter 2022 Financial Results and Operational ProgressNASDAQ:CDAKCodiak BioSciences Inc
04/05/202215:27Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CDAKCodiak BioSciences Inc
02/05/202208:00GlobeNewswire Inc.Codiak Appoints David Mauro, M.D., Ph.D., as Chief Medical OfficerNASDAQ:CDAKCodiak BioSciences Inc
 Showing the most relevant articles for your search:NASDAQ:CDAK

Su Consulta Reciente

COIN
ETHUSD
Ethereum
USI
USTECH100
US Tech 100
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
SOLUSD
Solana
USOTC
RHHBY
Roche (QX)
AMEX
XLF
Financial Select Sector
NYSE
JPM
JP Morgan Chase
AMEX
XLV
Health Care Select Sector
CCOM
SILVER
SILVER
USOTC
BASFY
BASF (QX)
AMEX
XLE
Energy Select Sector SPDR
USOTC
BNPQY
BNP Paribas (QX)
NYSE
NKE
Nike
NYSE
CVX
Chevron
NASDAQ
TSLA
Tesla
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados